Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect

Details for Australian Patent Application No. 2006256387 (hide)

International Classifications

Event Publications

24 January 2008 PCT application entered the National Phase

PCT publication WO2006/131951 Priority application(s): WO2006/131951

26 August 2010 Assignment before Grant

PanGenetics B.V. The application has been assigned to PANGENETICS 110 BV

15 December 2011 Application Accepted

Published as AU-B-2006256387

29 March 2012 Opposition Lodged

Pfizer Limited has lodged an opposition against Abbott Research B.V.

28 June 2012 Opposition Withdrawn

The opposition by Pfizer Limited against Abbott Research B.V has been withdrawn.

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.